Weight-Loss Drugs Emerge as Potential Tool to Reduce Cancer Recurrence Risk

An in-depth look at the growing trend of prescribing GLP-1 weight-loss medications like Mounjaro and Wegovy to cancer patients in the US to prevent recurrence, the scientific rationale linking obesity to cancer, patient experiences, regulatory challenges, and the caution required regarding drug interactions and the need for more robust clinical trial data.